Naïve CD4+ T cells were labeled with CFSE and co-cultured with primary Th17 clones, and naïve CD4+ T-cell proliferation was determined

by FACS analysis of CFSE dilutions. As shown in Fig. 1E, we observed that these Th17 clones increased the proliferation of naïve T cells with several cell generations in the presence of OKT3, suggesting that these Th17 clones had effector T-cell function. Furthermore, Th1-C1, a Th1 cell line derived from a melanoma TILs Rucaparib in vitro which served as an effector T-cell control, also increased the proliferation of naïve T cells. In contrast, a CD4+CD25+ Treg line, which served as a suppressive control, strongly inhibited the proliferation of naïve CD4+ T cells. We confirmed these data using buy Talazoparib 3H-thymidine incorporation assays and obtained

consistent results 27. Taken together, our studies show that we had established Th17 clones derived from TILs and that possessed characteristics of the Th17 lineage. Recent studies in humans and mice have shown that Th17 cells retain greater developmental plasticity than other types of T-cell lineages 7, 18–20. In order to maintain the cell line stability and to obtain the quantities of Th17 cells needed for future studies, we attempted to expand these Th17 clones in vitro with a standard protocol, using irradiated allogeneic PBMCs in the presence of soluble OKT3 (100 ng/mL) and IL-2. This strategy has been successfully used to expand tumor-reactive TILs for adoptive transfer immunotherapy in cancer patients 40. After each of three expansion cycles, the expanded Th17 cells were rested for 3–5 days and then analyzed for their phenotypes. We first determined IL-17, IL-4, IFN-γ-producing

cell populations and FOXP3 expression in the Th17 cells using flow cytometric analyses. Results from a representative Th17 clone were shown in Fig. 2A. We unexpectedly found that the percentages of IL-17-producing cells markedly dropped following each unbiased expansion, from over 95% before expansion (E0) to only 60% after the third expansion (E3). In contrast, the percentages of IFN-γ-producing and FOXP3+ cells were significantly Etofibrate increased in the Th17 clones after three rounds of expansion, from 3.7 to over 60% and from 2 to 57%, respectively (Fig. 2A). Furthermore, increased proportions of IL-17+IFN-γ+ and IL-17+FOXP3+ double-positive cell populations were observed following expansion (40 and 42%, respectively, after the third round of expansion) (Fig. 2A). In addition, the percentages of IL-4-producing T-cell populations were low (<2%) in all expanded Th17 clones, and this did not change with the expansion. In addition, we obtained similar results from the other Th17 clones shown in Supporting Information Fig. 1. Notably, these expanded Th17 clones (E1–E3) maintained the same TCR-Vβ gene expression patterns as did the original Th17 clones (E0) (Fig. 1B and data not shown), suggesting the preservation of homogeneous clonality with progressive expansion.